Arcturus Therapeutics Holdings Inc (ARCT)
16.91
-0.16
(-0.94%)
USD |
NASDAQ |
Nov 22, 16:00
16.94
+0.03
(+0.18%)
After-Hours: 20:00
Arcturus Therapeutics Holdings Shares Outstanding: 27.09M for Nov. 5, 2024
Shares Outstanding Chart
Historical Shares Outstanding Data
Date | Value |
---|---|
November 05, 2024 | 27.09M |
September 30, 2024 | 27.08M |
August 02, 2024 | 27.04M |
June 30, 2024 | 27.04M |
May 03, 2024 | 26.93M |
April 22, 2024 | 26.93M |
April 15, 2024 | 26.92M |
March 31, 2024 | 26.92M |
March 04, 2024 | 26.92M |
December 31, 2023 | 26.83M |
November 10, 2023 | 26.72M |
September 30, 2023 | 26.72M |
August 02, 2023 | 26.60M |
June 30, 2023 | 26.57M |
May 02, 2023 | 26.56M |
April 28, 2023 | 26.56M |
April 15, 2023 | 26.56M |
March 31, 2023 | 26.56M |
March 21, 2023 | 26.56M |
December 31, 2022 | 26.56M |
December 23, 2022 | 26.56M |
December 19, 2022 | 26.56M |
November 02, 2022 | 26.49M |
September 30, 2022 | 26.49M |
August 05, 2022 | 26.58M |
Date | Value |
---|---|
June 30, 2022 | 26.43M |
May 04, 2022 | 26.42M |
April 29, 2022 | 26.42M |
April 15, 2022 | 26.42M |
March 31, 2022 | 26.41M |
February 23, 2022 | 26.38M |
December 31, 2021 | 26.37M |
November 03, 2021 | 26.36M |
September 30, 2021 | 26.35M |
August 05, 2021 | 26.33M |
June 30, 2021 | 26.33M |
May 05, 2021 | 26.32M |
April 22, 2021 | 26.32M |
April 01, 2021 | 26.32M |
March 31, 2021 | 26.32M |
February 24, 2021 | 26.28M |
February 19, 2021 | 26.28M |
December 31, 2020 | 26.19M |
December 10, 2020 | 25.86M |
November 02, 2020 | 24.49M |
September 30, 2020 | 24.47M |
September 18, 2020 | 24.47M |
August 05, 2020 | 24.39M |
July 31, 2020 | 24.36M |
June 30, 2020 | 20.61M |
Shares Outstanding Definition
The volume of stock shares issued by the company and in the hands of the public. This number entails how much is being traded in the open market. A decreasing shares outstanding over time may be the result of company buybacks. Companies frequently make stock buybacks and retire those buybacks as treasury stock.
Shares Outstanding Range, Past 5 Years
15.14M
Minimum
Dec 11 2019
27.09M
Maximum
Nov 05 2024
24.79M
Average
26.39M
Median
Shares Outstanding Benchmarks
Bioventus Inc | 65.37M |
Fulcrum Therapeutics Inc | 53.94M |
Pfizer Inc | 5.667B |
AIM ImmunoTech Inc | 63.71M |
Protalix BioTherapeutics Inc | 73.63M |